secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2024-04-23T23:59:59+00:00
Accession:  0001022079-24-000096
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics Q1 revenue $2.37B (+1.5% YoY); raises full-year adjusted EPS to $8.72-$8.97
--------------------------------------------------------------------------------

- Revenue $2.366B, up 1.5% YoY; base business revenue grew nearly 6%.
- Reported diluted EPS $1.72 (down 3.4%); adjusted diluted EPS $2.04 (flat YoY).
- Full-year 2024 guidance raised: revenue $9.40B-$9.48B, adjusted EPS $8.72-$8.97.
- Invigorate initiative driving productivity; growth in brain, women's, and cardiometabolic health.
- Cash from operations $154M (+64.8%); capex $104M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207924000096/0001022079-24-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207924000096/dgx-20240423.htm
  HTML page:      https://secwatch.observer/filing/0001022079-24-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer